Ravi Ramjeesingh

19PUBLICATIONS
95CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 26, 2026
Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinoma.

|Apr 27, 2026
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025.

|Mar 07, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Daniel J Renouf, James T Topham, Jonathan M Loree

|Feb 26, 2026
Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma.

Thomas Samson, Maral Aali, Darien McBride

|Jul 25, 2025
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program.

Philip Q Ding, Vincent C Tam, Ravi Ramjeesingh

|Jul 02, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Jennifer J Knox, Gun Ho Jang, Robert C Grant

Pageof 4

Frequent Collaborators

6 joint publications

Sharlene Gill

5 joint publications

Mustapha Tehfé

4 joint publications

Jennifer J Knox

4 joint publications

Stephanie Snow